non-enantiomer analysis
非對映異構體分析
identifying non-enantiomers
鑑定非對映異構體
non-enantiomer content
非對映異構體含量
presence of non-enantiomers
非對映異構體的存在
non-enantiomer separation
非對映異構體分離
detecting non-enantiomers
檢測非對映異構體
non-enantiomer impurity
非對映異構體雜質
non-enantiomer ratio
非對映異構體比例
assessing non-enantiomers
評估非對映異構體
non-enantiomer standard
非對映異構體標準
the drug candidate was identified as a non-enantiomer, complicating the synthesis process.
該藥物候選物被鑒定為非對映異構體，使合成過程變得複雜。
our research focused on the separation of a non-enantiomer mixture using chiral chromatography.
我們的研究重點是使用手性色譜法分離非對映異構體混合物。
the non-enantiomer exhibited significantly lower biological activity compared to the desired enantiomer.
與期望的對映異構體相比，非對映異構體表現出顯著較低的生物活性。
we analyzed the product to confirm the absence of a non-enantiomer impurity.
我們分析了產品以確認不存在非對映異構體雜質。
the non-enantiomer's properties were thoroughly investigated for potential applications.
對非對映異構體的特性進行了深入研究，以評估其潛在應用。
the synthesis yielded a racemic mixture containing a non-enantiomer component.
合成產生了一種含有非對映異構體成分的外消旋混合物。
regulatory guidelines require strict control of non-enantiomer levels in pharmaceutical products.
法規指南要求對藥品中的非對映異構體含量進行嚴格控制。
the chiral shift revealed the presence of a non-enantiomer in the sample.
手性位移揭示了樣本中存在非對映異構體。
we developed a new method for selectively removing the non-enantiomer from the reaction mixture.
我們開發了一種新方法，用於選擇性地從反應混合物中去除非對映異構體。
the non-enantiomer's impact on the overall reaction kinetics was carefully assessed.
仔細評估了非對映異構體對整體反應動力學的影響。
the presence of a non-enantiomer can affect the drug's efficacy and safety profile.
非對映異構體的存在可能影響藥物的療效和安全性。
non-enantiomer analysis
非對映異構體分析
identifying non-enantiomers
鑑定非對映異構體
non-enantiomer content
非對映異構體含量
presence of non-enantiomers
非對映異構體的存在
non-enantiomer separation
非對映異構體分離
detecting non-enantiomers
檢測非對映異構體
non-enantiomer impurity
非對映異構體雜質
non-enantiomer ratio
非對映異構體比例
assessing non-enantiomers
評估非對映異構體
non-enantiomer standard
非對映異構體標準
the drug candidate was identified as a non-enantiomer, complicating the synthesis process.
該藥物候選物被鑒定為非對映異構體，使合成過程變得複雜。
our research focused on the separation of a non-enantiomer mixture using chiral chromatography.
我們的研究重點是使用手性色譜法分離非對映異構體混合物。
the non-enantiomer exhibited significantly lower biological activity compared to the desired enantiomer.
與期望的對映異構體相比，非對映異構體表現出顯著較低的生物活性。
we analyzed the product to confirm the absence of a non-enantiomer impurity.
我們分析了產品以確認不存在非對映異構體雜質。
the non-enantiomer's properties were thoroughly investigated for potential applications.
對非對映異構體的特性進行了深入研究，以評估其潛在應用。
the synthesis yielded a racemic mixture containing a non-enantiomer component.
合成產生了一種含有非對映異構體成分的外消旋混合物。
regulatory guidelines require strict control of non-enantiomer levels in pharmaceutical products.
法規指南要求對藥品中的非對映異構體含量進行嚴格控制。
the chiral shift revealed the presence of a non-enantiomer in the sample.
手性位移揭示了樣本中存在非對映異構體。
we developed a new method for selectively removing the non-enantiomer from the reaction mixture.
我們開發了一種新方法，用於選擇性地從反應混合物中去除非對映異構體。
the non-enantiomer's impact on the overall reaction kinetics was carefully assessed.
仔細評估了非對映異構體對整體反應動力學的影響。
the presence of a non-enantiomer can affect the drug's efficacy and safety profile.
非對映異構體的存在可能影響藥物的療效和安全性。
探索常見搜尋詞彙